Latest News

  • Alkermes Announces Recipients of 1st Annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program Read More
  • Alkermes' Corporate Presentation to be Webcast at the 37th Annual J.P. Morgan Healthcare Conference Read More
  • Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis Read More

Investors

Working at Alkermes